NCIt definition : A preparation of autologous T-lymphocytes that have been genetically modified to co-express
three transgenes using the Sleeping Beauty (SB) transposon system, including a chimeric
antigen receptor (CAR) targeting an undisclosed tumor-associated antigen (TAA), a
membrane-bound IL-15 (mbIL15) and a safety/kill switch, with potential immunostimulating
and antineoplastic activities. Upon introduction of the autologous PRGN-3006 T-cells
into the patient, these T-cells target, bind to and induce selective toxicity in cells
expressing this particular TAA. IL-15 is a pro-survival cytokine that is required
for the maintenance of long-lived CD8 memory T-cells. Use of mbIL15 preserves T stem-cell
memory (TSCM) through sustained IL-15 signaling, improves T-cell persistence and potentiates
the immune response against tumor cells. The safety switch can promote selective elimination
of the CAR-T cells. The SB system permits integration of the CAR, the IL-15 fusion
variant and safety switch transgenes into T-cells without the need for viral vectors
and accelerates the manufacturing process.;